Physician profile
Bianca Munoz
NPI 1508436452
$1,082.64
in general payments reported to CMS, 2019-2025
12 companies · $642 in 2025
The $642 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.46 · 2022: $275 · 2023: $29.11 · 2024: $122 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $336.21 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $189.09 | 2023-2025 | Zepbound, Mounjaro, Trulicity |
| Pfizer INC. | $126.13 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $86.06 | 2025 | Zoryve |
| Exact Sciences Corporation | $81.84 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $73.60 | 2025 | |
| Abbvie INC. | $62.58 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $53.09 | 2022-2025 | Farxiga |
| Abbott Laboratories | $22.10 | 2022 | |
| Glaxosmithkline, LLC. | $18.81 | 2025 | Shingrix, Arexvy |
| Kyowa Kirin, INC. | $17.65 | 2025 | |
| Phadia US INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Munoz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.